The US FDA has cleared electroCore LLC's gammaCore non-invasive vagus nerve stimulation hand-held device for treatment of cluster headaches, the first FDA-cleared indication the company has earned.
The FDA clearance of the cluster headache indication for gammaCore, via the de novo pathway, opens the door for electroCore's...







